Embed Size (px)
Citation preview
Nanotechnology in Drug Discovery- Development and Delivery
Dr. Basavaraj K. NanjwadeKLE University College of Pharmacy
Belgaum-590010E-mail: [email protected]
Cell No: 00919742431000
Nanotechnology
• Nanotechnology breakthrough research in Pharmaceutical & Biopharmaceutical Industry.
• Nanotechnology, a field of science and technology that aims to control matter at the atomic and molecular level.
19/08/2011 Srinivas College of Pharmacy, Mangalore 2
Drug Discovery and Development
• Validate specific targets
• Discover the right molecule (potential drug) to interact with the target chosen
• Test the new compound in the lab and clinic for safety and efficacy and
• Gain approval and get the new drug into the hand of doctors and patients.
19/08/2011 Srinivas College of Pharmacy, Mangalore 3
Drug Discovery and Development
• Success requires immense resources The best scientist minds, highly sophisticated
technology and complex project management.
It is also takes persistence and sometimes luck.
Ultimately the process of drug discovery brings hope and relief to millions of patients
19/08/2011 Srinivas College of Pharmacy, Mangalore 4
Drug Development and Delivery
• The multi-disciplinary field of nanotechnology is making small device, closer and closer to reality.
• Manipulate and organize matter on the nano-scale.
19/08/2011 Srinivas College of Pharmacy, Mangalore 5
Drug Development and Delivery
• Drug filled nano-capsules, release their biological compounds on contact with cancers only.
• Nanotechnology will be applied at all stages of drug development, from formulations for optimal delivery to diagnostic applications in clinical trials.
19/08/2011 Srinivas College of Pharmacy, Mangalore 6
Discovery
19/08/2011 7Srinivas College of Pharmacy, Mangalore
Development
19/08/2011 8Srinivas College of Pharmacy, Mangalore
Pre-Discovery
19/08/2011 9Srinivas College of Pharmacy, Mangalore
Pre-Discovery
• Before any potential new medicine can be discovered, scientist work to understand the disease to be treated as well as possible.
• Try to understand how the genes are altered, how that affects the proteins.
19/08/2011 Srinivas College of Pharmacy, Mangalore 10
Target Identification
• Once have enough understanding of the underlying cause of a disease, pharmaceutical researchers select a “target” for a potential new medicine.
• A target is generally a single molecule, such as gene or protein, which is involved in a particular disease.
• Early stage in drug discovery it is critical to researchers pick a target that is ‘drugable”.
19/08/2011 Srinivas College of Pharmacy, Mangalore 11
Target Validation• After choosing a potential target, scientist
must show that it actually is involved in the disease and can be acted upon by a drug.
• Target validation is crucial to help scientists avoid research paths that look promising, but ultimately lead to dead ends.
• Researchers demonstrate that a particular target is relevant to the disease being studied through complicated experiments in both living and in animal models of disease
19/08/2011 Srinivas College of Pharmacy, Mangalore 12
Drug Discovery and Development Activities
19/08/2011 13Srinivas College of Pharmacy, Mangalore
Drug Discovery and Development
19/08/2011 14Srinivas College of Pharmacy, Mangalore
Lead Compound
• Nature
• De Novo
• High-throughput screening
• Biotechnology
19/08/2011 Srinivas College of Pharmacy, Mangalore 15
Early Safety Tests
• Absorbed into the bloodstream
• Distributed to the proper site of action in the body
• Metabolized efficiently and effectively
• Successfully excreted from the body and
• Demonstrated to be not toxic19/08/2011 Srinivas College of Pharmacy, Mangalore 16
Lead Optimization
• Lead compounds that survive the initial screening are then “optimized” or altered to make them more effective and safer.
• Hundreds of different variations or “analogues” of the initial leads are made and tested.
• Early stage, researchers begin to think about how the drug will be made, considering formulation, delivery mechanism and large-scale manufacturing
19/08/2011 Srinivas College of Pharmacy, Mangalore 17
Preclinical Testing
• Scientist carry out in vitro and in vivo test
• In vitro test are experiments conducted in the lab, usually carried out in the test tube and beakers (“vitro” is “glass” in Latin)
• In vivo studies are those in living cell cultures and animal models (“vivo” is “life” in Latin)
19/08/2011 Srinivas College of Pharmacy, Mangalore 18
Development of IND (Investigational New drug)
• IND application contains information in three broad areas:
1.Animal Pharmacology and Toxicology Studies
2.Manufacturing Information of drug including manufacturer, composition, stability and controls
3.Clinical Protocols and Investigator Information
19/08/2011 Srinivas College of Pharmacy, Mangalore 19
Phase 1 Clinical Trial
• Phase I studies are carried out in healthy volunteers, which are small in number – usually 20 to 100.
• The purpose of phase I studies is to mainly determine safety profile.
19/08/2011 Srinivas College of Pharmacy, Mangalore 20
Phase 2 Clinical Trial
• Phase 2 includes the early controlled clinical studies conducted to obtain some preliminary data on the effectiveness of the drug.
• Phase 2 studies are typically well-controlled, closely monitored, and conducted in a relatively small number of patients, usually involving several hundred people
19/08/2011 Srinivas College of Pharmacy, Mangalore 21
Phase 3 Clinical Trial
• The additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug.
• Phase 3 studies usually include several hundred to several thousand people.
19/08/2011 Srinivas College of Pharmacy, Mangalore 22
Manufacturing
• Going from small-scale to large-scale manufacturing is a major undertaking.
• In many cases, companies must build a new manufacturing facility or reconstruct an old one because the manufacturing process is different from drug to drug.
• Each facility must meet strict FDA guidelines for Good Manufacturing Practices (GMP)
19/08/2011 Srinivas College of Pharmacy, Mangalore 23
Ongoing Studies Phase 4 Trial
• Phase IV, also known as Post Marketing Surveillance is also carried out once the drug is approved and marketed.
• The aim of Phase IV is to find out safety profile in large patient pool across the world and to establish the safety profile of the drug.
19/08/2011 Srinivas College of Pharmacy, Mangalore 24
NDA Review Process
19/08/2011 25Srinivas College of Pharmacy, Mangalore
ANDA/AADA Review Process
19/08/2011 26Srinivas College of Pharmacy, Mangalore
OTC Drug Monograph Process
19/08/2011 27Srinivas College of Pharmacy, Mangalore
Successful Therapy Combines Drug Discovery and Delivery
19/08/2011 28Srinivas College of Pharmacy, Mangalore
Nanotech Components
19/08/2011 29Srinivas College of Pharmacy, Mangalore
Nanotechnology Regulatory
19/08/2011 30Srinivas College of Pharmacy, Mangalore
Nanotechnology Collaboration
19/08/2011 31Srinivas College of Pharmacy, Mangalore
Research Priorities
19/08/2011 32Srinivas College of Pharmacy, Mangalore
Suggested Topics and Modules
19/08/2011 33Srinivas College of Pharmacy, Mangalore
Nanoparticles in the context of Biopharmaceuticals
19/08/2011 34Srinivas College of Pharmacy, Mangalore
Current Nanoparticle Products
19/08/2011 35Srinivas College of Pharmacy, Mangalore
Current Nanoparticle Products
19/08/2011 36Srinivas College of Pharmacy, Mangalore
Nanoparticles: As Emulsion
19/08/2011 37Srinivas College of Pharmacy, Mangalore
Nanoparticles: Reduce Size
19/08/2011 38Srinivas College of Pharmacy, Mangalore
Nanoparticles: Grow Them
19/08/2011 39Srinivas College of Pharmacy, Mangalore
Nanoparticles: Emulsion/Diffusion
19/08/2011 40Srinivas College of Pharmacy, Mangalore
Structure
19/08/2011 41Srinivas College of Pharmacy, Mangalore
Release
19/08/2011 42Srinivas College of Pharmacy, Mangalore
Drug Delivery Carriers
19/08/2011 Srinivas College of Pharmacy, Mangalore 43
Methods of Drug Delivery
19/08/2011 Srinivas College of Pharmacy, Mangalore 44
19/08/2011 Srinivas College of Pharmacy, Mangalore 45
THANKING YOUE-mail: [email protected]
Cell No: 0091 9742431000
19/08/2011 46Srinivas College of Pharmacy, Mangalore
